Quick Takeaways
- Aklog Lishan filed SCHEDULE 13D for PAVmed Inc. Common Stock, par value $0.001 per share (PAVM).
- Disclosed ownership: 5.1%.
- Date of event: 02 Apr 2026.
Aklog Lishan - 02 Apr 2026 SCHEDULE 13D Report for PAVmed Inc. Common Stock, par value $0.001 per share (PAVM)
- Filing Manager
- Aklog Lishan
- Reporting Manager
- Aklog Lishan
- Symbol
- PAVM
- Shares outstanding
- 7,236,627 shares
- Disclosed Ownership
- 369,068 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13D
- Filing time
- 09 Apr 2026, 20:56:41 UTC
- Date of event
- 02 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Aklog Lishan disclosed 5.1% ownership in PAVmed Inc. Common Stock, par value $0.001 per share (PAVM) on 02 Apr 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 09 Apr 2026, 20:56.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Aklog Lishan | 5.1% | 369,068 | 369,023 | 45 | /s/ Lishan Aklog, M.D. | Lishan Aklog, M.D. | 0001665074 |